We are live on ! Find out more
PVI

Pura Vida Investments Portfolio holdings

AUM $14.9M
1-Year Est. Return 38.76%
This Fund
S&P 500
This Quarter Est. Return
+24.68%
1 Year Est. Return
+38.76%
3 Year Est. Return
+26.8%
5 Year Est. Return
+25.03%
10 Year Est. Return
+1,723.84%
AUM
$3.51B
AUM Growth
+$758M
Cap. Flow
+$605M
Cap. Flow %
17.25%
Top 10 Hldgs %
47.4%
Holding
285
New
108
Increased
67
Reduced
35
Closed
69

Top Buys

Rank Stock Value
1
IMDX
Insight Molecular Diagnostics
IMDX
+$28.2M
2
ALGN icon
Align Technology
ALGN
+$19.3M
3
APR
Apria, Inc. Common Stock
APR
+$17.3M
4
CUTR
Cutera, Inc.
CUTR
+$14.8M
5
CMIIU
CM Life Sciences II Inc. Unit
CMIIU
+$13M

Top Sells

Rank Stock Value
1
VCEL icon
Vericel Corp
VCEL
+$14.4M
2
AFIB
Acutus Medical Inc
AFIB
+$13.5M
3
SHC icon
Sotera Health
SHC
+$12.9M
4
OPCH icon
Option Care Health
OPCH
+$12.1M
5
BNGO icon
Bionano Genomics
BNGO
+$10.3M

Sector Composition

Rank Sector Weight
1 Healthcare 33%
2 Industrials 1.49%
3 Materials 0.46%
4 Financials 0.45%
5 Consumer Staples 0.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SOLY
126
DELISTED
Soliton, Inc.
SOLY
$4.18M 0.12%
+237,650
New +$3.04M
NNOX icon
127
PUT
Nano X Imaging
NNOX
$71M
$4.14M 0.12%
100,000
+80,000
+400% +$4.31M
NAUT icon
128
Nautilus Biotechnolgy
NAUT
$114M
$4.07M 0.12%
+295,554
New +$4.1M
CMPS
129
Compass Pathways
CMPS
$1.97B
$3.98M 0.11%
108,146
+5,152
+5% +$226K
EXAS
130
PUT
DELISTED
Exact Sciences
EXAS
$3.95M 0.11%
+30,000
New +$4.11M
FBRX icon
131
Forte Biosciences
FBRX
$1.57B
$3.89M 0.11%
4,539
+1,939
+75% +$1.59M
EPIX
132
DELISTED
ESSA Pharma
EPIX
$3.85M 0.11%
132,483
+22,334
+20% +$519K
KURA icon
133
Kura Oncology
KURA
$882M
$3.51M 0.1%
124,240
+48,440
+64% +$1.53M
MRNA icon
134
Moderna
MRNA
$25.4B
$3.51M 0.1%
+26,791
New +$3.88M
BFLY.WS
135
DELISTED
Butterfly Network Inc Warrants
BFLY.WS
$3.44M 0.1%
+533,372
New +$4.35M
CLDX icon
136
Celldex Therapeutics
CLDX
$3.52B
$3.37M 0.1%
+163,615
New +$3.76M
CFMS
137
DELISTED
Conformis, Inc. Common Stock
CFMS
$3.36M 0.1%
+135,842
New +$3.66M
GILD icon
138
Gilead Sciences
GILD
$168B
$3.27M 0.09%
+50,602
New +$3.26M
ATRC icon
139
CALL
AtriCure
ATRC
$2.22B
$3.26M 0.09%
+49,800
New +$3.07M
TVTX icon
140
Travere Therapeutics
TVTX
$5.86B
$3.16M 0.09%
+126,533
New +$3.5M
BFLY icon
141
Butterfly Network
BFLY
$2.52B
$3.09M 0.09%
183,765
-101,235
-36% -$2M
FRONU
142
DELISTED
Frontier Acquisition Corp. Units
FRONU
$2.98M 0.08%
+300,000
New +$3.04M
MTACU
143
DELISTED
MedTech Acquisition Corporation Unit
MTACU
$2.92M 0.08%
290,047
-459,953
-61% -$4.89M
VINC
144
DELISTED
Vincerx Pharma, Inc. Common Stock
VINC
$2.89M 0.08%
7,476
+275
+4% +$111K
MIST icon
145
Milestone Pharmaceuticals
MIST
$141M
$2.71M 0.08%
467,640
+17,640
+4% +$129K
FNCH
146
DELISTED
Finch Therapeutics Group, Inc. Common Stock
FNCH
$2.58M 0.07%
+5,333
New +$2.72M
ACAD icon
147
PUT
Acadia Pharmaceuticals
ACAD
$5.07B
$2.58M 0.07%
+100,000
New +$4.4M
ZNTL icon
148
Zentalis Pharmaceuticals
ZNTL
$307M
$2.46M 0.07%
+56,776
New +$2.44M
ABGI
149
DELISTED
ABG Acquisition Corp. I
ABGI
$2.44M 0.07%
+246,507
New +$2.48M
VXRT
150
CALL
DELISTED
Vaxart
VXRT
$2.43M 0.07%
+401,500
New +$3.09M
4 5
6
7 8

Similar funds

BCA
Boundary Creek Advisors New York $15.3M AUM 0.41% 1-Year Est. Return
RC
Raine Capital New York $14.1M AUM 33.16% 1-Year Est. Return
DOFI
DCVC Opportunity Fund II Palo Alto, California $13.9M AUM 8.04% 1-Year Est. Return
SCI
SkyBridge Capital II New York $13.1M AUM 3.36% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
GBCP
Glade Brook Capital Partners Greenwich, Connecticut $12.8M AUM
SCTC
Samsung C&T Corporation Seoul, South Korea $17.2M AUM 23.45% 1-Year Est. Return
M
MetLife New York $12.3M AUM 29% 1-Year Est. Return

Pura Vida Investments's Q1 2021 Portfolio in Review

As of Q1 2021, Pura Vida Investments held 285 positions worth $3.51B, up 28% from $2.75B the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Pura Vida Investments deployed $605M of net new capital in Q1 2021, opening 108 new positions and adding to 67 existing holdings. Its largest new stake was Align Technology: 35,000 shares worth $19M.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, down from 34% a quarter earlier, followed by Industrials and Materials.

On the sell side, the largest reduction was Vericel Corp, an estimated $14.4M trimmed.

  • Pura Vida Investments's largest Q1 2021 buy was Align Technology: 35,000 shares worth $19M.
  • Pura Vida Investments added most to Insight Molecular Diagnostics in Q1 2021, an estimated $28.2M increase.
  • Pura Vida Investments's biggest Q1 2021 reduction was Vericel Corp, cutting an estimated $14.4M.
  • Pura Vida Investments fully exited Acutus Medical Inc in Q1 2021, selling an estimated $13.5M.
  • Pura Vida Investments's ten largest holdings make up 47% of its $3.51B portfolio in Q1 2021.
  • Pura Vida Investments opened 108 new positions and closed 69 in Q1 2021.
  • Pura Vida Investments's portfolio value rose 28% quarter-over-quarter to $3.51B.

Based on Pura Vida Investments's 13F filing for Q1 2021, filed 12 May 2021.